Delivering on the Promise of New Modalities: WuXi AppTec Interview Series
Featured
As part of WuXi AppTec’s ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we have launched a new interview series in 2022 – “Delivering on the Promise of New Modalities” – so leading voices of R&D can share how their approaches are addressing the barriers standing in the way of breakthroughs.
CEO and Co-founder, Envisagenics; Secretary, The Alliance for Artificial Intelligence in Healthcare
CEO, Orum Therapeutics
President, CEO & Co-Founder, Actym Therapeutics
Zachary Hornby
President & CEO, Boundless Bio
Nikole Kimes
CEO & Co-Founder, Siolta Therapeutics
Reagan Jarvis
Co-Founder & CEO, Anocca AB
Geoff Hamilton
Co-Founder & CEO, Stemson Therapeutics
Yann Chong Tan
Founder & CEO, Nuevocor
George Wu
Co-Founder & CEO, Amberstone Biosciences
Andrea van Elsas
CSO, Abata Therapeutics
Elvire Gouze
CEO & Founder, Innoskel SAS, France
Mark Frohlich
CEO, Indapta Therapeutics
Karen Kozarsky
Co-Founder & Chief Scientific Officer, SwanBio Therapeutics
James McArthur
President & CEO, PepGen
Daniel Getts
CEO, Co-Founder & Board Director, Myeloid Therapeutics
Amber Van Laar
VP Clinical Development, AskBio
Kunwoo Lee
CEO, GenEdit
Ray Tabibiazar
CEO & Chairman, SalioGen Therapeutics
David Main
President & CEO, Notch Therapeutics
Susan Dillon
CEO, Aro Biotherapeutics
